Validity Assessment of the "LabForGames Warning" Serious Game

November 20, 2018 updated by: Antonia Blanie, Université Paris-Sud

The use of simulation in medical education has been associated with positive results in the acquisition of knowledge, skills, behaviors and patient outcome. Serious games are useful educational tools since they allow both theory and practice training for an important number of learners, simultaneously. However, few studies have evaluated the validity and effectiveness of serious games.

Our simulation unit (LabForSIMS- Faculté de Médecine Paris-Sud, France) has developed a serious game named "LabForGames Warning" for nursing students with the following learning objectives: to recognize and to address the degradation of a patient's clinical condition and to work on the issue of inter-professional communication. The aim of the present study is to determine content and construct validities of the "LabForGames Warning" serious game before its use as a healthcare professional training tool.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This observational single-center open study will be conducted in the simulation center of the Paris-Sud medical school (LabForSIMS). After written consent, the study population (nurses and nursing students) will attend a three hours simulation session with the "LabForGames Warning" serious game and will be divided into three groups :

  • Nursing students
  • New Nurses: Nurses with < 2 years experience
  • Expert Nurses: Intensive nurses, with ≥ 4 years experience post graduate.

During three hours, each learner will play with the three different cases of the "LabForGames Warning" serious game then an auto-evaluation will be recorded.

The primary outcome measure was the evaluation of the construct validity:

The score (/100) and the duration (min) of each case of the serious game will be reported in order to assess whether the difference of the measures is related to the difference of skills between the three groups. An auto-evaluation of clinical reasoning will also be recorded.

The secondary outcome measure was the evaluation of content and face validities. For content validity, the content and parameters will be tested by the nurses ≥ 4 years experienced (Ten-point Likert scale) For face validity, the students' satisfaction and the resemblance between the virtual game and the real life clinical practice will be evaluated in the three groups (Ten-point Likert scale).

Study Type

Observational

Enrollment (Actual)

71

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Le Kremlin-Bicêtre, France, 94276
        • Faculté de médecine Paris Sud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Voluntary divided into three groups :

  • "Nursing students" group
  • "New nurses" group: Nurses with < 2 years experience
  • "Expert nurses" group: Intensive nurses (with ≥ 4 years experience post graduate)

Description

Inclusion Criteria:

  • Nursing students or nurses with < 2 years experience or intensive nurses (with ≥ 4 years experience post graduate)
  • and having agreed to participate

Exclusion Criteria:

  • Subjects incapable of giving consent: incapacitated (subjects under guardianship), minors (< 18 years)
  • Refusal to participate in to the study Refusal to sign in the confidentiality clause

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
"Nursing students" group
nursing students
During three hours, each learner will play with the three different cases of the "LabForGames Warning" serious game.
"New nurses" group
Nurses with < 2 years experience
During three hours, each learner will play with the three different cases of the "LabForGames Warning" serious game.
"Expert nurses" group
Intensive nurses (with ≥ 4 years experience post graduate)
During three hours, each learner will play with the three different cases of the "LabForGames Warning" serious game.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The score (/100) of each case of the serious game
Time Frame: 60 min
The score (/100) of each case of the serious game will be reported in order to assess whether the difference of the measures is related to the difference of skills between the three groups (Evaluation of the construct validity). An auto-evaluation of clinical reasoning will also be recorded.
60 min
the duration (min) of each case of the serious game
Time Frame: 60 min
The duration (min) of each case of the serious game will be reported in order to assess whether the difference of the measures is related to the difference of skills between the three groups (Evaluation of the construct validity).
60 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The content and parameters of the serious game
Time Frame: 30 min
For content validity, the content and parameters of the serious game will be tested by the nurses ≥ 4 years experienced (Ten-point Likert scale)
30 min
Learners' satisfaction
Time Frame: 5 min
For face validity, the learners' satisfaction and the resemblance between the virtual game and the real life clinical practice will be evaluated in the three groups (Ten-point Likert scale).
5 min
The resemblance between the virtual game and the real life clinical practice
Time Frame: 25 min
For content validity, the resemblance between the virtual game and the real life clinical practice will be evaluated in the three groups (Ten-point Likert scale).
25 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonia Blanié, M.D, Université Paris Sud, 91 400 Orsay, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

September 30, 2017

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 21, 2017

First Posted (Actual)

March 28, 2017

Study Record Updates

Last Update Posted (Actual)

November 23, 2018

Last Update Submitted That Met QC Criteria

November 20, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • LabForSIMS-002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education

Clinical Trials on serious game

Subscribe